RENEE LIVESAY: Open Payments
NPI 1003520230 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,462 in 71 payments from 13 companies in 2025. Trend: 2023 $409 · 2024 $1,165 · 2025 $1,462
Food & beverage: $1,377Education: $85
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 39 | $685 |
| Boston Scientific Corporation | 12 | $266 |
| Janssen Biotech, Inc. | 6 | $187 |
| COLOPLAST CORP | 4 | $77 |
| Astellas Pharma US Inc | 2 | $58 |
| Novartis Pharmaceuticals Corporation | 1 | $33 |
| Baxter Healthcare | 1 | $32 |
| Teleflex LLC | 1 | $28 |
| UROGEN PHARMA, INC. | 1 | $23 |
| Olympus America Inc. | 1 | $21 |
Products named: GEMTESA, AMS 700, ERLEADA, Xtandi, Luja Coude, PLUVICTO, TISSEEL, BARRIGEL.
Industry payments across TX — which companies pay providers there.
